IN8bio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.

About INAB

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. 

CEO
William T. Ho
CEOWilliam T. Ho
Employees
19
Employees19
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2016
Founded2016
Employees
19
Employees19

INAB Key Statistics

Market cap
48.51M
Market cap48.51M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
94.85K
Average volume94.85K
High today
$2.20
High today$2.20
Low today
$1.92
Low today$1.92
Open price
$2.20
Open price$2.20
Volume
55.52K
Volume55.52K
52 Week high
$9.42
52 Week high$9.42
52 Week low
$1.75
52 Week low$1.75

INAB Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10
ActualExpected Nov 10
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.